Article

Quantitative imaging of schwannoma captures heterogeneity and accelerates preclinical testing, revealing distinct impacts of targeted therapies

2026-03-26

Abstract excerpt

Schwannomas are debilitating hallmarks of familial schwannomatoses and common sporadic tumors that form on spinal and cranial nerves. Drug-based therapies for schwannoma are desperately needed but their development has been extremely slow and disappointing, impeded particularly by the poorly understood and surprisingly complex and heterogeneous biology of schwannomas, and by the inefficient use of physiologically...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 26f29d4a-658b-5d99-a329-7bbf43ea8bf7
DOI: 10.64898/2026.03.24.714069

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Quantitative imaging of schwannoma captures heterogeneity and accelerates preclinical testing, revealing distinct impacts of targeted therapiesDOI 10.64898/2026.03.24.714069Read

Cellular mechanisms of heterogeneity in <i>NF2</i> -mutant schwannomaSemantic proximity Read

Cellular mechanisms of heterogeneity in NF2-mutant schwannoma.Semantic proximity Read

Generation of Noninvasive, Quantifiable, Orthotopic Animal Models for NF2-Associated Schwannoma and Meningioma.Semantic proximity Read

Schwannomatosis: a Realm Reborn: year oneSemantic proximity Read

Classification of schwannomas and the new naming convention for “neurofibromatosis-2”: Genetic updates and international consensus recommendationSemantic proximity Read

Functional interactions between neurofibromatosis tumor suppressors underlie Schwann cell tumor de-differentiation and treatment resistanceSemantic proximity Read

High-Dimensional Imaging of Vestibular Schwannoma Reveals Distinctive Immunological Networks Across Histomorphic Niches in <i>NF2</i> -related SchwannomatosisSemantic proximity Read

Modeling iPSC-derived human neurofibroma-like tumors in mice uncovers the heterogeneity of Schwann cells within plexiform neurofibromasSemantic proximity Read

Novel patient‐derived xenograft and cell line models for therapeutic screening in NF2 ‐associated schwannomaSemantic proximity Read

Creation of an international registry to support discovery in schwannomatosis.Semantic proximity Read

Preclinical assessments of the MEK inhibitor PD-0325901 in a mouse model of neurofibromatosis type 1Semantic proximity Read

Quantitative assessment of whole-body tumor burden in adult patients with neurofibromatosis.Semantic proximity Read